The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

[40] Patients may be at higher risk of developing fractures and this may be related to the dose or the duration of use of PPIs. If long-term PPI therapy is to be used, monitoring of bone density ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...